Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 4849  

    Article Cited by others

ORIGINAL ARTICLE

Empiric Therapy with Low-Dose I-131 in Differentiated Cancer Thyroid: What is the Magic Number?

Shinto Ajit S, Kamaleshwaran K K, Shibu Deepu K, Vyshak K, Antony Joppy

Year : 2013| Volume: 12| Issue : 2 | Page no: 61-64

   This article has been cited by
 
1 Preablation Diagnostic Whole-Body Scan vs Empiric Radioactive Iodine Ablation in Differentiated Thyroid Cancer: Cost-effectiveness Analysis
Simran Arjani,Patrick L. Quinn,Ravi J. Chokshi
Otolaryngology–Head and Neck Surgery. 2021; 164(6): 1172
[Pubmed]  [Google Scholar] [DOI]
2 Measurement of cumulative radiation exposure to children and adolescents in contact with outpatients treated with low dose radioactive iodine (131I)
Khaled Salman,Shereen Wagieh,Aquib Bakhsh,Tarek Al-Monshy,Omnia Talaat,Musaed Al-Malki,Manal Al-Ezzi,Ashraf Fouda,Gihad Hamid
Journal of the Egyptian National Cancer Institute. 2020; 32(1)
[Pubmed]  [Google Scholar] [DOI]
3 Risk of Breast Cancer in Patients with Thyroid Cancer Receiving or Not Receiving 131I Treatment: A Nationwide Population-Based Cohort Study
Chun-Yi Lin,Cheng-Li Lin,Wen-Sheng Huang,Chia-Hung Kao
Journal of Nuclear Medicine. 2016; 57(5): 685
[Pubmed]  [Google Scholar] [DOI]

 

Read this article